premature ejaculation. The inability to control ejaculation sufficiently for both partners to enjoy sexual interaction
Conditions
Interventions
Intervention 1: The placebo prescripted for once every night and halfhour before sexual intercourse for 3 weeks. For anytime placebo used locally two puffs (each puff about 25/0 cc) on the penis and t
Treatment - Drugs
The placebo prescripted for once every night and halfhour before sexual intercourse for 3 weeks. For anytime placebo used locally two puffs (each puff about 25/0 cc) on the penis and two puffs scrotum
The drug prescripted for once every night and halfhour before sexual intercourse for 3 weeks. For anytime drug used locally two puffs (each puff about 25/0 cc) on the penis and two puffs scrotum and t
Sponsors
trita company
tradiional medicine faculty of TUMS
Eligibility
Sex/Gender
Male
Age
75 Years to 55 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1. The men 20 to 40 years old. 2. Steady sexual activity at least 6 month with a female partner. 3. The history of premature ejaculation more than 6 months. 4. Time IELT less than 1 minute. 5. The ability to begin and maintain an erection (IIEF score of 22). 6. Sexual intercourse at least one time per week. 7. Informed consent of patient to entering the project and filling the consent form from him. None Inclusion criteria: 1. A history of severe organic diseases such as uncontrolled diabetes, heart failure, acute renal failure, urinary surgery, urinary tract infections in male and partner. 2. A history of severe psychiatric illness and poor mental state. 3. PEDT questionnaire score less than 11. 4. The history of alternate premature ejaculation. 5. Erectile Dysfunction (IIEF score less than 22) 6. Anatomic abnormalities of the penis that causes unsuccessful penetration. 7. Substance abuse such as alcohol, opium and smoking. 8. Using drugs that affect the sexual function, including phosphodiesterase inhibitors and selective serotonin reuptake inhibitors and opioids and antidepressants and anti-anxieties and hormonal drugs during project. 9. Extreme hot and dry temperament. 10. The warm and wet temperament with semen acuity. 11. Any history of hypersensitivity to black cumin, frankincense and olives. 12. The history of any type of mucosal and dermal allergy. Exclusion criteria: 1. using of drugs and substance that effective on sexual performance. 2. Intercourse activity less than twice in three weeks. 3. The using of condom and local anesthetic. 4. The sever decrease in male libido or sexual partner. 5. The use of any vaginally cream, ointment or gel by partner. 6. Severe and intolerable adverse events associated with the drug based on a questionnaire PRO- CTCAE. 7. The Withdrawing of participant from continuing the project with any reason.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to Ejaculation. Timepoint: before & 3 weeks after intervention. Method of measurement: PEDT qustioner - chornometer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Sexuall desire. Timepoint: before & 3 weeks after intervention. Method of measurement: IEEF qustioner. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactsyedhamed moosaviasil
TUMS
Outcome results
None listed